David H. Coy

Q: What Schools Are Affiliated With David H. Coy

David H. Coy is affiliated with the following schools: University of Ottawa, Johns Hopkins University, Sapienza University of Rome, University of Auckland, University of Manchester, Tulane University

David H. Coy's AcademicInfluence.com Rankings

David H. Coy

Biology

#4299

World Rank

#6428

Historical Rank

Endocrinology

#26

World Rank

#30

Historical Rank

Molecular Biology

#326

World Rank

#331

Historical Rank

Neuroscience

#447

World Rank

#466

Historical Rank

biology Degrees

Download Badge

Biology

Why Is David H. Coy Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David H. Coy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. (1989) (1841)
Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. (1991) (622)
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. (1974) (555)
The antimicrobial peptides and their potential clinical applications. (2019) (494)
Dynorphin immunocytochemistry in the rat central nervous system (1982) (311)
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. (1997) (306)
Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. (1993) (278)
CNS effects of peripherally administered brain peptides. (1979) (275)
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. (1973) (271)
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. (1974) (247)
Nonopiate effects of dynorphin and des-Tyr-dynorphin. (1982) (231)
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas (2008) (224)
Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs. (1982) (184)
NEW HYPOTHALAMIC HORMONE, CORTICOTROPIN-RELEASING FACTOR, SPECIFICALLY STIMULATES THE RELEASE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN MAN (1982) (184)
Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. (1988) (183)
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin. (1977) (177)
Progress in the development of potent bombesin receptor antagonists. (1991) (170)
DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATS (1975) (163)
Reduction of distress vocalization in chicks by opiate-like peptides (1978) (159)
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. (1985) (157)
Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. (1982) (155)
Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors* (1997) (155)
Radioimmunoassay of somatostatin. (1978) (155)
An analog of enkephalin having prolonged opiate-like effects in vivo. (1977) (154)
[Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo (1991) (150)
CORTICOTROPHIN RELEASING FACTOR: RESPONSES IN NORMAL SUBJECTS AND PATIENTS WITH DISORDERS OF THE HYPOTHALAMUS AND PITUITARY (1984) (148)
Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain (1997) (147)
Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat. (1977) (146)
Growth Hormone Release Inhibiting Hormone in Acromegaly (1974) (145)
Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin. (1977) (141)
Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone. (1974) (140)
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. (1976) (137)
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. (1976) (133)
Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. (1978) (132)
Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. (1997) (131)
Solid phase synthesis of peptides containing the CH2NH peptide bond isostere (1987) (129)
In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. (1988) (126)
Somatostatin Receptor-mediated Signaling in Smooth Muscle (1996) (126)
Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin. (1976) (125)
Glucagon control of fasting glucose in man. (1974) (123)
Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats (1976) (123)
Renal responses to intra-arterial administration of adrenomedullin in dogs. (1996) (122)
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J (1990) (121)
MIF-I's differential actions as an opiate antagonist (1979) (120)
The somatostatin receptor subtype on rat enterochromaffinlike cells. (1994) (119)
Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion (2010) (119)
Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. (2003) (118)
The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK (1990) (117)
An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-α (TNF-α)-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-α. (1998) (117)
Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations. (1976) (115)
Super-active analogs of growth hormone-releasing factor (1-29)-amide. (1984) (113)
Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat (1982) (113)
Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6. (1976) (111)
Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary. (1982) (110)
Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. (1986) (105)
The half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LH-RH) in man. (1973) (104)
Somatostatin receptor-targeted anti-cancer therapy. (2011) (103)
Distribution of 3H-α-MSH in rat brain (1976) (102)
Adrenomedullin: a hypotensive hormone in man. (1997) (100)
Neuropharmacological actions of enkephalin after systemic administration. (1976) (100)
des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. (1990) (98)
Enkephalin and other peptides reduce passiveness (1978) (97)
Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. (1998) (97)
Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. (1994) (96)
Proceedings: Effect of somatostatin on motilin levels and gastric emptying. (1975) (96)
Potent bombesin receptor antagonists distinguish receptor subtypes. (1990) (94)
Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. (2002) (92)
Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog (1976) (92)
Synthesis and biological properties of (D-Ala-6, des-Gly-NH2-10)-LH-RH ethylamide, a peptide with greatly enhanced LH- and FSH- releasing activity. (1974) (90)
GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASE (1983) (90)
Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. (1989) (89)
Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. (1990) (86)
Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. (1997) (85)
Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. (1980) (84)
Additional evidence that small amounts of a peptide can cross the blood-brain barrier (1979) (83)
Recent approaches to fertility control based on derivative of LH-RH. (1980) (81)
An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. (1998) (81)
Insights into bombesin receptors and ligands: Highlighting recent advances (2015) (80)
Solid phase synthesis of growth hormone-release inhibiting factor. (1973) (79)
Synthesis and biological actions of prosomatostatin. (1980) (79)
Synthesis and biological properties of (Leu-6)-LH-RH and (D-Leu-6,desGly-NH210)-LH-RH ethylamide. (1974) (77)
LH‐RH Agonists and Antagonists (1980) (77)
Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. (1997) (77)
Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells* (2004) (74)
A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. (1988) (73)
Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide. (1987) (72)
Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. (1997) (71)
Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3* (1998) (70)
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. (1985) (70)
Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells. (1995) (70)
Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. (1991) (69)
Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain (1982) (69)
Structure-activity studies on the N-terminal region of growth hormone releasing factor. (1985) (69)
A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. (1995) (68)
Galanin binding sites in rat gastric and jejunal smooth muscle membrane preparations (1990) (68)
Highly potent cyclic disulfide antagonists of somatostatin. (1999) (68)
Long-term Infusion of Growth Hormone Release Inhibiting Hormone in Acromegaly: Effects on Pituitary and Pancreatic Hormones (1974) (67)
Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5. (1999) (67)
Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors. (1992) (66)
Reversal of Somatostatin Inhibition of Insulin and Glucagon Secretion (1976) (66)
Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells (1988) (66)
Adrenomedullin, amylin, calcitonin gene-related peptide and their fragments are potent inhibitors of gastric acid secretion in rats. (1997) (65)
THE CORTISOL RESPONSE TO CORTICOTROPHIN‐RELEASING FACTOR IS BLUNTED IN OBESITY (1988) (64)
Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. (1990) (64)
Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. (1987) (64)
Peptide antagonists of LH-RH: large increases in antiovulatory activities produced by basic D-amino acids in the six position. (1982) (63)
Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline). (1990) (63)
Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3* (2001) (62)
Cardiopulmonary pharmacology of enkephalins in the conscious dog (1981) (61)
A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists (1994) (61)
Receptor-specific somatostatin analogs: correlations with biological activity. (1996) (61)
[D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists. (1987) (61)
Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. (1987) (61)
Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism (1984) (61)
Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. (1992) (61)
Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. (2004) (60)
Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats (2011) (60)
Absence of LH-RH binding sites in corpora lutea from rhesus monkeys (Macacca mulatta). (1981) (60)
LH-releasing activity of potent LH-RH analogs in vitro. (1975) (60)
Developmental, behavioral, and opiate receptor changes after prenatal or postnatal β-endorphin, CRF, or Tyr-MIF-1 (1985) (59)
Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. (1996) (59)
Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. (1993) (58)
Pituitary adenylate cyclase-activating polypeptide relaxes rat gastrointestinal smooth muscle. (1992) (58)
Receptor-binding properties of gonadotropin-releasing hormone derivatives. Prolonged receptor occupancy and cell-surface localization of a potent antagonist analog. (1984) (58)
Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. (1992) (58)
Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception (1985) (57)
Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. (1996) (56)
Radioimmunoassay of DSIP-like material in rat brain (1978) (56)
Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release (1994) (56)
Effect of somatostatin on myoelectrical activity of small bowel. (1978) (56)
Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone. (1975) (55)
Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. (1993) (55)
Examination of somatostatin involvement in the inhibitory action of GIP, GLP‐1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue (1998) (54)
Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues. (1993) (54)
Permeability of blood-brain barrier to DSIP peptides (1981) (54)
Endorphin analogs with potent and long-lasting analgesic effects (1977) (54)
Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone. (1974) (54)
Peptides readily penetrate the blood-brain barrier: Uptake of peptides by synaptosomes is passive (1976) (53)
Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus. (1979) (53)
Inhibition of pancreatic secretion by enkephalin and morphine in dogs (1978) (53)
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. (2006) (53)
Characterization of Vasoactive Intestinal Peptide (VIP) receptors in mammalian lung (1986) (52)
Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? (2003) (52)
Gastrin secretion from human antral G cells in culture. (1990) (52)
Radioimmunoassay of DSIP-like material in human blood: Possible protein binding (1981) (52)
Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. (1986) (52)
Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype. (1995) (51)
Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. (1996) (51)
Solid phase reductive alkylation techniques in analogue peptide bond and sidechain modification (1988) (51)
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, αVβ3/αVβ5 and MMP-2/-9 (2007) (51)
In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors (2006) (50)
Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. (1998) (50)
GIP6–30amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1–42action in vitro (1997) (50)
Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone. (1974) (50)
An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs. (1985) (50)
Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist (2001) (50)
Endogenous opiates: 1981 (1982) (50)
Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release. (1993) (50)
Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat (1992) (49)
Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R). (1999) (49)
Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: Some correlations with protein binding (1982) (48)
Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. (1986) (48)
Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. (1998) (48)
Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats (2013) (48)
Corticotropin releasing factor (CRF): immunocytochemical localization and radioimmunoassay (RIA). (1982) (48)
Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist. (2001) (48)
Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. (1977) (48)
Peptone stimulates gastrin secretion from the stomach by activating bombesin/GRP and cholinergic neurons. (1992) (48)
Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors. (1995) (47)
Increased analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine enkephalinamide. (1978) (47)
VIP Attenuation of the Severity of Experimental Pancreatitis Is Due to VPAC1 Receptor-Mediated Inhibition of Cytokine Production (2005) (46)
Circular dichroism and absorption study of the structure of methionine-enkephalin in solution. (1978) (46)
Unusual anti-reproductive properties of the analog [d-Leu6,des-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in male rats. (1978) (45)
SUPPRESSION OF GONADOTROPHIN RELEASE IN MAN BY AN INHIBITORY ANALOGUE OF L.H.-RELEASING HORMONE (1977) (45)
Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, β-endorphin, and (D-Ala2)-β-endorphin: Effects on eating, drinking and activity measures in rats (1979) (45)
Combined Endopeptidase Inhibition and Adrenomedullin in Sheep With Experimental Heart Failure (2002) (45)
Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital. (1982) (45)
Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig. (2002) (45)
CNS effects of somatostatin. (1978) (45)
Peripheral administration of hypothalamic peptides results in CNS changes. (1978) (45)
Evidence for direct production of somatostatin-14 from a larger precursor than somatostatin-28 in a phaeochromocytoma (1983) (45)
A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: a possible role for CRH-binding protein. (1992) (44)
Blockade of brain bombesin/GRP receptors increases food intake in satiated rats. (1993) (44)
Blockage of ovulation in rats by inhibitory analogs of luteinizing hormones-releasing hormone. (1976) (44)
Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. (1995) (43)
Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. (1984) (43)
Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography. (1978) (43)
Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* (2001) (43)
IMPAIRMENT OF PLATELET FUNCTION BY GROWTH-HORMONE RELEASE- INHIBITING HORMONE (1975) (43)
Neuropeptides and the blood-brain barrier in goldfish (1978) (43)
DSIP — more than a sleep peptide? (1980) (42)
Gastrointestinal secretory, motor, circulatory, and metabolic effects of prosomatostatin. (1981) (42)
Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide (1986) (42)
Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. (1998) (41)
Dissociation of effects of LH-RH analogs on pituitary regulation and reproductive behavior (1980) (41)
Differential penetration of DSIP peptides into rat brain (1982) (41)
Endogenous opiates: Through 1978 (1979) (40)
Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs (1984) (40)
Unusual Anti-Reproductive Properties of the Analog [d-Leu6,Des-Gly- N H 2 10 ]-Luteinizing Hormone-Releasing Hormone Ethylamide in Male Rats**Supported in part by National Institutes of Health Grant 5 P50 HD08338. (1978) (40)
Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. (1998) (40)
Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone. (1982) (40)
MIF-I suppresses deprivation-induced fluid consumption in rats (1980) (40)
Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration. (1990) (40)
Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats (1991) (40)
PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells (1999) (40)
Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2 (2016) (39)
Potent antagonists of somatostatin: synthesis and biology. (1998) (39)
Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat. (1985) (39)
EFFECTS OF PROSOMATOSTATIN ON GROWTH HORMONE AND PROLACTIN RESPONSE TO ARGININE IN MAN Comparison with Somatostatin (1981) (39)
Antagonistic analogs of luteinizing hormone-releasing hormone are mast cell secretagogues. (1986) (39)
Endogenous opiates: 1980 (1981) (39)
Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. (2002) (38)
High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). (1988) (38)
Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin. (1978) (38)
Somatostatin and its Analogs. (2016) (38)
Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes (1989) (38)
Thermoregulatory and locomotor effects of DSIP: Paradoxical interaction with d-amphetamine (1980) (38)
Organ distribution of radioactivity and disappearance of radioactivity from plasma after administration of (3H) luteinizing hormone-releasing hormone to mice and rats. (1974) (38)
Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. (1991) (38)
Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs (2011) (38)
Gonadotrophin releasing hormone analogues. (1978) (37)
Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. (1994) (37)
PACAP(6-38) inhibits the growth of prostate cancer cells. (1998) (37)
Neonatal administration of met-enkephalin facilitates maze performance of adult rats (1980) (37)
Isolation and structure of several peptides from porcine hypothalami. (1980) (37)
Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone. (1982) (37)
Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors (2009) (37)
Effect of substitutions in position 12 of bombesin on antagonist activity (1989) (36)
Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice. (2001) (36)
Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors (2002) (36)
(D-Ala 6, Des-Gly-NH 2 10)-LH-RH-ethylamide: a new analogue with unusually high LH-RH-FSH-RH activity. (1974) (36)
Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors (2002) (36)
Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine. (1980) (36)
Inhibitory action of galanin on gastric acid secretion in pentobarbital-anesthetized rats. (1989) (36)
THE INTERACTION OF GROWTH HORMONE RELEASING HORMONE WITH OTHER HYPOTHALAMIC HORMONES ON THE RELEASE OF ANTERIOR PITUITARY HORMONES (1986) (36)
Uptake of iodinated luteinizing hormone releasing hormone analogs in the pituitary. (1977) (36)
Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. (1999) (36)
Regulation of acid secretion by bombesin/GRP neurons of the gastric fundus. (1991) (35)
Breakdown of enkephalin and endorphin analogs by brain extracts (1977) (35)
A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells. (2001) (35)
Effects of an enkephalin analog on complex learning in the rhesus monkey (1979) (35)
Suppression of postovulatory gonadotropin levels does not affect corpus luteum function in rhesus monkeys. (1983) (35)
A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists (2015) (35)
The pharmacology of endorphin modulation of chick distress vocalization (1984) (35)
Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 (2004) (35)
Control of gonadotrophic hormone release in trout: influence of synthetic LH-RH and LH-RH analogues in vivo and in vitro. (1981) (34)
Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. (1997) (34)
Modulation by galanin of growth hormone and gonadotropin secretion from perifused pituitary and median eminence of prepubertal male calves. (1997) (34)
Systemic administration of endorphins selectively alters open field behavior of rats (1978) (34)
Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics. (2012) (34)
Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice. (2000) (34)
Entry of DSIP peptides into dog CSF: Role of physicochemical and pharmacokinetic parameters (1986) (34)
The Wound Dressings and Their Applications in Wound Healing and Management (2019) (34)
Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region. (1990) (34)
Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy (1981) (33)
Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. (1982) (33)
Pituitary Adenylate Cyclase Activating Polypeptide: A Neuropeptide with Potent Inotropic and Coronary Vasodilatory Effects in Neonatal Pig Hearts (1993) (33)
A peptide inhibitor of luteinizing hormone-releasing hormone (LH-RH). (1973) (33)
Investigation of the role of tryptophan in the luteinizing hormone-releasing hormone. (1974) (33)
Activity of VIP, somatostatin and other peptides in the mouse vas deferens assay (1978) (33)
GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF (2001) (33)
Structural requirements at the N-terminus of urotensin II octapeptides (2002) (33)
N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity. (2001) (32)
Anovulatory effect of a LHRH antagonist in women. (1981) (32)
Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. (1990) (32)
An adjustable release rate linking strategy for cytotoxin-peptide conjugates. (2003) (32)
GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro. (1997) (32)
Role of Different Bombesin Receptor Subtypes Mediating Contractile Activity in Cat Upper Gastrointestinal Tract (1998) (32)
Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues. (1989) (32)
Structure-activity studies on the N-terminal region of glucagon. (1984) (32)
Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats (2013) (31)
Solid-phase synthesis of porcine vasoactive intestinal peptide. (2009) (31)
Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin. (1983) (31)
Luteinizing hormone-releasing hormone analogs with increased anti-ovulatory activity. (1981) (31)
Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. (1995) (31)
Low doses of naloxone and MIF-1 peptides increases fluid consumption in rats (1981) (31)
[Leu13-ψ(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells (1988) (31)
Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors (2005) (31)
The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling (2015) (31)
Stimulation of luteinizing hormone (LH) and follicle-stimulating hormone by (D-Leu6, des-Gly10-NH2)-LH-releasing hormone ethylamide after subcutaneous, intravaginal, and intrarectal administration to women. (1977) (30)
Effects of endorphin and enkephalin analogs on fear habituation in goldfish (1978) (30)
Activation of Somatostatin Receptor Subtype 2 Inhibits Insulin Secretion in the Isolated Perfused Human Pancreas (2003) (30)
Effect of simple amino acid replacements on the biological activity of luteinizing hormone-releasing hormone. (1973) (30)
Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. (1997) (30)
Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone. (1980) (30)
Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line. (1999) (30)
Mu and delta opiate receptors in rat brain are affected by GTP but not by MIF-1 (1981) (30)
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. (2007) (30)
Effect of reductive alkylation of D-lysine in position 6 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. (1987) (30)
Synthesis and biological activity of LH-RH antagonists modified in position 1 (1982) (30)
Urethane-induced somatostatin mediated inhibition of gastric acid: reversal by the somatostatin 2 receptor antagonist, PRL-2903. (1999) (29)
The antigenic determinant of the LH-releasing hormone for three different antisera. (1975) (29)
Effect of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH. (1991) (29)
Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368* (2001) (29)
Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors (2013) (29)
Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion. (2000) (29)
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. (1991) (29)
Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships (2018) (29)
Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE2 (2000) (29)
Degradation of delta sleep inducing peptide (DSIP) and its analogs by brain extracts (1977) (29)
Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. (1990) (29)
Facilitation of sexual receptivity in the rat by an ovulation-inhibiting analog of LHRH (1981) (28)
Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL. (2001) (28)
Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. (1985) (28)
Targeted Chemotherapy Using a Cytotoxic Somatostatin Conjugate to Inhibit Tumor Growth and Metastasis in Nude Mice (2008) (28)
D-amphetamine-induced hypothermia and hypermotility in rats: Changes after systemic administration of beta-endorphin (1980) (28)
Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II (2013) (28)
Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide–drug conjugate via activating somatostatin receptor type II (2016) (28)
[Des-Met14]Bombesin analogues function as small cell lung cancer bombesin receptor antagonists (1991) (28)
Radioimmunoassay of MIF-1/Tyr-MIF-1-like material in rat pineal (1980) (28)
The effects of an LH-RH antagonist ([N-Ac-D-Trp(1)(3), D-p-Cl-Phe(2), D-Phe(6), D-Ala(10)]-LH-RH) during the preovulatory period of the rhesus monkey. (1981) (27)
Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. (1984) (27)
Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats (1982) (27)
Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin. (1990) (27)
Polyfluoroalkylamine derivatives of luteinizing hormone-releasing hormone. (1975) (27)
Delta sleep-inducing peptide (DSIP)-like material is absorbed by the gastrointestinal tract of the neonatal rat. (1983) (27)
Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (27)
μ-Opiate binding and morphine antagonism by octapeptide analogs of somatostatin (1987) (27)
Gonadotropin-releasing activity of two highly active and long-acting analogs of luteinizing hormone-releasing hormone after subcutaneous, intravaginal, and oral administration. (1975) (27)
Role of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. (1988) (26)
Receptor-mediated uptake of GnRH agonist and antagonists by cultured gonadotropes: Evidence for differential intracellular routing (1986) (26)
Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans. (1983) (26)
Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. (1976) (26)
The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. (1985) (26)
Effect of synthetic human pancreatic growth hormone-releasing factors on plasma growth hormone concentrations in lactating cows. (1984) (25)
HYPOTHALAMIC HORMONE INTERACTION IN ACROMEGALY (1975) (25)
Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. (1990) (25)
Differential effects of neuropeptides on short-term memory in primates (1981) (25)
The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man. (1974) (25)
Stimulation of growth hormone release in anesthetized and conscious pigs by synthetic human pancreatic growth hormone-releasing factor [hpGRF(1-29)-NH2] (1985) (25)
Effects of Camptothecin Conjugated to a Somatostatin Analog Vector on Growth of Tumor Cell Lines in Culture and Related Tumors in Rodents (2004) (24)
Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): Affinities, potencies and selectivity in multiple native and BnR transfected cells (2010) (24)
Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. (1996) (24)
CHAPTER 26 – Multiple Independent Actions of Neuropeptides on Behavior (1981) (24)
Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells (2005) (24)
Effects of β-(Tyr9)melantropin-(9–18) decapeptide on passive and active avoidance behavior and on open-field activity of rats (1981) (24)
Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. (2000) (24)
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells (2006) (24)
Analgesia after peripheral administration of enkephalin and endorphin analogues (1979) (24)
Luteinizing hormone releasing hormone. Solid-phase synthesis of a 5-phenylalanine analog possessing high biological activity. (1973) (23)
MIF-I and postsynaptic receptor sites for dopamine (1979) (23)
In vitro inhibition of LH release by a synthetic antagonist of LH-releasing hormone (LH-RH). (1974) (23)
Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. (1989) (23)
Reduced gastric acid inhibitory effect of a pGIP(1–30)NH2 fragment with potent pancreatic amylase inhibitory activity (1992) (23)
Growth hormone responses to growth hormone-releasing hormine (1–29)-NH2 and a D-Ala2 analog in normal men (1985) (23)
Convenient apparatus for preparative polyacrylamide gel electrophoresis and its use in purification of three porcine neurophysins. (1971) (23)
Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. (1991) (23)
Effect of somatostatin on gastrointestinal secretions and peptic ulcer production in cats. (1977) (23)
Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1986) (22)
Comparison of Somatuline (BIM‐23014) and somatostatin on endocrine and exocrine activities in the rat (1991) (22)
Pituitary adenylate cyclase-activating peptide stimulates rat pancreatic secretion via secretin and cholecystokinin releases. (1998) (22)
HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. (2018) (22)
An in vivo assay for anti-LH-RH and anti-FSH-RH activity of inhibitory analogues of LH-RH. (1975) (22)
Synthesis and biological properties of the 2-L-beta-(pyrazolyl-1)alanine analogs of luteinizing hormone-releasing hormone and thyrotropin-releasing hormone. (1975) (22)
Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat (1997) (22)
Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. (2000) (22)
Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. (1991) (22)
Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP) (2003) (22)
Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region. (1986) (22)
(D‐Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists (1988) (22)
Analogs of luteinizing hormone-releasing hormone containing derivatives of phenylalanine in place of tyrosine. (1973) (22)
Radioautographic localization of radioactivity in rat brain after intraventricular or intracarotid injection of 3H-L-prolyl-L-leucyl glycinamide (1975) (22)
Endogenous opiates: 1979 (1980) (22)
Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction. (1993) (22)
Possible non-narcotic component to action of opiate peptides on tonic immobility (1979) (22)
Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths. (1987) (22)
Human pancreatic polypeptide inhibits insulin release in the rat. (1981) (21)
Effect of the CH2NH and CH2NAc peptide bond isosteres on the antagonistic and histamine releasing activities of a luteinizing hormone-releasing hormone analogue. (1988) (21)
Somatostatin and analogs inhibit endogenous synaptic plasma membrane protein phosphorylation in vitro. (1983) (21)
Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice (1985) (21)
Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. (1988) (21)
Increased and prolonged LH-RH/FSH-RH activity of synthetic (D-Ala6, Des-Gly-NH210)-LH-RH-ethylamide in normal women. (1975) (21)
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase (2011) (21)
Bombesin-like peptides stimulate somatostatin release from rat fundic D cells in primary culture. (1997) (21)
Expression of somatostatin receptor genes and their role in inhibiting Cl- secretion in HT-29cl.19A colonocytes. (1995) (21)
Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat (1976) (21)
Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. (1995) (21)
Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction. (1991) (21)
Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor (2008) (21)
Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands (2006) (21)
Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. (2002) (20)
Inhibition of the postcastration rise of luteinizing hormone and follicle-stimulating hormone in female rhesus monkeys (Macaca mulatta) by the administration of a luteinizing hormone-releasing hormone inhibitory analog ([N-Ac-D-Trp1-3,D-p-Cl-phe2,D-Phe6,D-Ala10]-LH-RH). (1981) (20)
Galanin inhibits pancreatic amylase secretion in the pentobarbital-anesthetized rat (1991) (20)
Responses to human CGRP, ADM, and PAMP in human thymic arteries. (2003) (20)
Inhibitory effect of galanin on basal and pentagastrin-stimulated gastric acid secretion in rats. (1990) (20)
SSTR2 mediates the somatostatin-induced increase in intracellular Ca(2+) concentration and insulin secretion in the presence of arginine vasopressin in clonal beta-cell HIT-T15. (2002) (20)
Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). (2005) (20)
Vasoactive intestinal peptide–camptothecin conjugates inhibit the proliferation of breast cancer cells (2007) (20)
Behavioral effects after systemic injection of opiate peptides (1980) (20)
[Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. (1980) (20)
Characterization of bombesin binding sites in the rat stomach. (1997) (20)
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector (2007) (20)
Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao. (1996) (20)
Serum gonadotropin concentrations and ovarian response in ewes treated with analogs to LH-RH/FSH-RH. (1976) (20)
Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs. (1981) (20)
Bombesin receptor antagonists differentiate receptor subtypes in rat brain. (1993) (20)
Autoradiographic localization of neuromedin B binding sites in rat brain (1990) (20)
Synthesis and biological properties of ovine corticotropin-releasing factor (CRF). (1982) (20)
Brain β-endorphin-like immunoreactivity in adult rats given β-endorphin neonatally (1981) (20)
Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat (2001) (19)
Blockade of LH release and ovulation in the rabbit with inhibitory analogues of luteinizing hormone releasing hormone. (1977) (19)
Disappearance and excretion of labeled α-MSH in man (1978) (19)
Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier. (1986) (19)
Cyclic analogues of luteinizing hormone-releasing hormone with significant biological activities. (1978) (19)
Suppressive effect of an inhibitory LHRH analog on the gonadotropin response to LHRH in normal women. (1980) (19)
Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2 (2017) (19)
Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats (1997) (19)
Proadrenomedullin NH2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells☆ (2000) (19)
Distribution of radioactivity in the organs of the rat and mouse after injection of L-(3H)prolyl-L-leucyl-glycinamide. (1975) (19)
Bombesin receptor subtype mediation of gastroenteropancreatic hormone secretion in rats (1994) (19)
Distinct receptors mediate gastrin-releasing peptide and neuromedin B-induced delay of gastric emptying of liquids in rats (1995) (19)
Production of immunoreactive pituitary adenylate cyclase activating polypeptide (PACAP) by human neuroblastoma cells, IMR-32: detection and characterization with monoclonal and polyclonal antibodies against different epitopes of PACAP. (1993) (19)
Serum LH, FSH and testosterone response to the administration of a new LH-RH analog, D-Trp6-LH-RH, in normal men. (1977) (19)
Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase (1984) (19)
Minimal side-chain protection can be a successful strategy in solid-phase peptide synthesis. (2009) (19)
Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. (2004) (18)
Proadrenomedullin NH2-terminal 20 peptide has direct vasodilator activity in the cat. (1997) (18)
Comparison of the anti-LH/FSH-RH and anti-ovulatory activities of (D-Phe2, D-Leu6)-LH-RH and (D-Phe2, D-Ala6)-LH-RH. (1976) (18)
In Vitro Histamine Release with LHRH Analogs (1987) (18)
Branched-chain analogues of luteinizing hormone-releasing hormone. (1978) (18)
Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model (2013) (18)
Fourth ventricular injection of the bombesin receptor antagonist [d-phe6]bombesin(6–13)methyl ester, but not BW2258U89, increases food intake in rats (1995) (18)
The Effect of Oral and Vaginal Administration of Synthetic LH-RH and [D-ALA6, DES GLY10-NH2]-LH-RH Ethylamide on Serum LH Levels in Ovariectomized, Steroid Blocked Rats 1 (1975) (18)
GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity (2001) (18)
Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2). (2000) (18)
Tyrosine-modified analogs of methionine-enkephalin and their effects on the mouse vas deferens (1980) (18)
Blockade of ovulation in rats by inhibitory analogs of luteinizing hormone-releasing hormone (1976) (18)
STUDY OF INHIBITORY EFFECTS OF AN ANTIANGIOGENIC SOMATOSTATIN-CAMPTOTHECIN CONJUGATE ON LASER-INDUCED CHOROIDAL NEOVASCULARIZATION IN RATS (2005) (17)
Peptides and the Blood-Brain Barrier (1980) (17)
STIMULATION OF LUTEINISING HORMONE (L.H.) RELEASE AFTER ORAL ADMINISTRATION OF AN ANALOGUE OF L.H. RELEASING HORMONE (1975) (17)
Structural requirements for galanin inhibition of pentagastrin-stimulated gastric acid secretion in conscious rats. (1992) (17)
Solid-phase synthesis and biological activities of gastrointestinal hormones: Secretin and motilin (1982) (17)
Effects of a novel bombesin antagonist analogue on bombesin-stimulated gastric acid secretion and growth hormone release in the pentobarbital-anesthetized rat. (1989) (17)
Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. (1991) (17)
Suppression of the positive feedback of estradiol benzoate on gonadotropin secretion by an inhibitory analog of luteinizing hormone-releasing hormone (LRH) in oophorectomized rhesus monkeys: evidence for a necessary synergism between LRH and estrogens. (1983) (17)
Smooth muscle cells from guinea pig stomach possess high-affinity galanin receptors that mediate relaxation. (1994) (17)
Systematic development of bombesin/gastrin-releasing peptide antagonists. (1992) (17)
[D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. (1987) (17)
Naloxone-reversible effects of d-Ala2-Met5-enkephalinamide-induced behavioral activity in rats. (1980) (16)
Somatostatin analogues and multiple receptors: possible physiological roles. (1995) (16)
Colonic smooth muscle cells possess a different subtype of somatostatin receptor from gastric smooth muscle cells. (1997) (16)
Superactive amidated COOH-terminal glucagon analogues with no methionine or tryptophan (1986) (16)
Purification and amino acid composition of constituents of rat neurophysin. (1972) (16)
Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies. (1995) (16)
Prolonged elevation of luteinizing hormone (LH) after intranasal administration of an analog of LH-releasing hormone. (1976) (16)
DSIP reduces amphetamine-induced hyperthermia in mice (1984) (16)
LHRH antagonists in females (1984) (16)
Experiments with a reported anorexigenic tripeptide: PyroGluHisGlyOH (1979) (15)
Effect of [D-Phe6] bombesin (6-13) methylester, a bombesin receptor antagonist, towards bombesin-induced contractions in the guinea-pig and rat isolated urinary bladder. (1992) (15)
Anti-Luteinizing Hormone (LH)-Releasing Activity of Several Analogues of LH-Releasing Hormone (1975) (15)
Clinical studies with d-TRP6-luteinizing hormone-releasing hormone in men with hypogonadotropic hypogonadism. (1978) (15)
Gliclazide directly inhibits arginine-induced glucagon release. (2002) (15)
Cytotoxic conjugates of peptide hormones for cancer chemotherapy (2008) (15)
STIMULATORY AND INHIBITORY ANALOGS OF LH-RH (1981) (15)
Novel urotensin II (UII) antagonists point to multiple receptor involvement in UII bioactivity (2000) (15)
Direct and indirect inhibition of ovulation in rats by an antagonist of luteinizing hormone-releasing hormone. (1985) (15)
Conformational study of super-active analogues of somatostatin with reduced ring size by XXXH nmr (1988) (15)
Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. (1998) (15)
Increased potency of four analogues of LH-releasing hormone in man. (1974) (15)
GRP-preferring bombesin receptor subtype mediates contractile activity in cat terminal ileum (1994) (14)
Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity. (1998) (14)
Pharmacokinetic evaluation of superactive analogues of growth hormone-releasing factor (1–29)-amide (1988) (14)
Is Notch Signaling a Specific Target in Hepatocellular Carcinoma? (2015) (14)
Effects of an LHRH antagonist on the time of occurrence and amplitude of the preovulatory LH surge, progesterone and estradiol secretion, and ovulation in superovulated Holstein heifers. (1994) (14)
Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo. (1980) (14)
Comparison of TRH and anorexigenic peptide on food intake and gastrointestinal secretions (1981) (14)
Galanin inhibits cholecystokinin secretion in STC-1 cells. (1995) (14)
Activation of human somatostatin receptor type 2 causes inhibition of cell growth in transfected HEK293 but not in transfected CHO cells. (1997) (14)
Attempts to programme ovulation with exogenous oestrogens and LH-RH analogue. (1975) (14)
Somatostatin Receptor-mediated Signaling in Smooth Muscle ACTIVATION OF PHOSPHOLIPASE C- 3 BY G AND INHIBITION OF ADENYLYL CYCLASE BY G AND G o (1996) (14)
Is the postovulatory release of follicle-stimulating hormone in the rabbit mediated by luteinizing hormone-releasing hormone? (1983) (14)
Suppression of LH-RH-induced ovulation in hamsters and rats by synthetic analogues of LH-RH. (1976) (14)
ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE WITH INCREASED BIOLOGICAL ACTIVITY PRODUCED BY D-AMINO ACID SUBSTITUTIONS IN POSITION 6 (1976) (14)
Autoradiographic evidence that zona glomerulosa and capsular vessels of the human adrenal cortex are provided with different subtypes of adrenomedullin receptors (1998) (14)
Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2, 3, 4, 25, 27 and/or 29 (1988) (14)
Interaction of ovine pituitary adenylate cyclase-activating peptide (PACAP-38) with rat lung membranes (1993) (14)
Metabolism of potent enkephalin analogs (FK 33–824, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin (1978) (13)
Galanin-induced relaxation in gastric smooth muscle cells is mediated by cyclic AMP (1994) (13)
COMPARISON OF LONG‐ACTING ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN MAN (1979) (13)
Somatostatin inhibits insulin release via SSTR2 in hamster clonal β-cells and pancreatic islets (2005) (13)
Synthesis and biological properties of (2-L-beta-(pyrazolyl-3)alanine)-luteinizing hormone-releasing hormone. (1974) (13)
Somatostatin‐receptor 2 (sst2)‐mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach (2005) (13)
Cyclic lactam analogues of ovine pituitary adenylate cyclase activating polypeptide (PACAP): Discovery of potent type II receptor antagonists (1994) (13)
Administration of human pancreatic growth hormone-releasing factor (GRF) analogs enhances responsiveness of cultured rat pituitary cells to GRF. (1984) (13)
Basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH) and its analogues. (1973) (13)
Comparison of enkephalin and atropine in the inhibition of vagally stimulated gastric and pancreatic secretion and gastrin and pancreatic polypeptide release in dogs (1982) (13)
Structure-CNS activity studies with the enkephalins. (1980) (13)
Stereoisomers of luteinizing hormone-releasing hormone. (1974) (13)
Effects of secretin and gastric inhibitory polypeptide on human pancreatic growth hormone-releasing factor(1-40)-stimulated growth hormone levels in the rat. (1983) (13)
Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys. (1983) (13)
Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor (1986) (13)
Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes (2016) (13)
Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice (1981) (13)
Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. (1983) (13)
Effects of anorexigenic peptide on gastric and pancreatic secretion. (1981) (13)
Behavioral effects of D-Ala2-β-endorphin in squirrel monkeys (1978) (13)
A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon (2003) (12)
Unusual dose-related effect of an endorphin analog in a complex maze (1980) (12)
Bombesin receptor antagonists: different classes and cellular basis of action. (1993) (12)
Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo 1 (2006) (12)
An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs. (1977) (12)
Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs. (1999) (12)
Investigation of cancer cell lines for peptide receptor-targeted drug development (2011) (12)
Clinical comparison of natural LH-RH, synthetic LH-RH, and two analogues of LH-RH. (1974) (12)
Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats (1983) (12)
Inverse relationship between onset and duration of EEG effects of six peripherally administered peptides (1981) (12)
Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal man (1977) (12)
Prolonged inhibition of growth hormone secretion by peripheral injection of bombesin is mediated by somatostatin in the rat. (1985) (12)
Plasma Progestins in Anestrous Ewes Treated with D-Leu Des GlyNH -LHRH Ethylamide (1977) (12)
Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. (1996) (12)
New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction. (1991) (12)
Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells. (1989) (12)
Inhibition of pancreatic secretion by enkephalin and morphine in dogs. (1978) (12)
Identification and initial characterization of a putative neuromedin B-type receptor from rat urinary bladder membranes. (1992) (12)
Inhibition of release in the baboon by inhibitory analogs of lutheinizing hormone releasing hormone. (1977) (12)
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro. (1975) (12)
Systemic injections of gastro-intestinal peptides alter behavior in rats (1980) (11)
Effects of an LHRH antagonist on gonadotrophin and oestradiol secretion, follicular development, oestrus and ovulation in Holstein heifers. (1989) (11)
The effect of treatment with an LHRH antagonist on the quality of day-7 embryos collected from superovulated Holstein heifers (1990) (11)
Actions of somatostatins on gastric smooth muscle cells. (1992) (11)
Bioactivity of growth hormone releasing hormone (1–29) analogues after SC injection in man (1989) (11)
Structure-Activity Relationship of LH and FSH Releasing Hormone (1975) (11)
Development of a method to test anti-LH-RH activity in rats. (1974) (11)
Isolation, structure, biological characterization, and synthesis of beta-[Tyr9]melanotropin-(9-18) decapeptide from pig hypothalami. (1980) (11)
ANALOGUES OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE (1975) (11)
Improved antagonists of luteinizing hormone-releasing hormone modified in position 7. (1985) (11)
Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat (1986) (10)
Selective Inhibition of Glucagon and Insulin Secretion by Somatostatin Analogs 1 (1979) (10)
LH-RH antagonists: Further analogs with ring-substituted aromatic residues (1981) (10)
Conformational study of somatostatin analogues in methanol at low temperature (1991) (10)
1 – Hypothalamic Peptide Hormones: Basic and Clinical Studies (1979) (10)
CNS ACTIONS OF PERIPHERALLY ADMINISTERED PEPTIDES: SOME UNRESOLVED ISSUES (1982) (9)
[D-Ala2,(F5)Phe4]-dynorphin1–13-NH2 (DAFPHEDYN): A potent analog of dynorphin 1–13 (1987) (9)
Influence of LH-RH agonists and antagonists on gonadotropin release in humans. (1980) (9)
Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients. (1976) (9)
Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LH-RH) in vitro (1976) (9)
Effect of a powerful antagonist of LH-RH on testicular function in prepubertal male rats. (1983) (9)
Correlation between in vivo inhibition of gonadotropin release induced by LH-RH and the blockade of ovulation by synthetic analogues of LH-RH. (1978) (9)
Suppression of gonadotropin release and ovulation in animals by inhibitory analogs of luteinizing hormone-releasing hormone. (1976) (9)
Influence of intracisternal injection of somatostatin analog receptor subtypes 2, 3 and 5 on gastric acid secretion in conscious rats (1995) (9)
Adenohypophyseal response to hypophysiotropic hormones in male obese Zucker rats. (1985) (9)
Isolation, structure and synthesis of a heptapeptide with in vitro ACTH-releasing activity from porcine hypothalamus. (1981) (9)
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs. (2004) (9)
Prolonged anti-luteinizing hormone/follicle-stimulating hormone-releasing activities of some synthetic antagonists of luteinizing hormone-releasing hormone. (1976) (9)
LH-RH antagonist inhibits gonadal steroid secretion in vitro (1985) (9)
Inhibition of bombesin-stimulated gastrin release from isolated canine G cells by bombesin antagonists. (1989) (9)
Organ removal and disappearance half-time of synthetic human pancreatic polypeptide. (1982) (9)
Opposite effects of CRF and ACTH on reserpine-induced hypothermia (1982) (9)
Distinguishing bombesin receptor subtypes using the oocyte assay. (1991) (9)
Inhibition of bombesin-stimulated gastrin release from isolated human G cells by bombesin analogs. (1990) (9)
Clinical studies with d-Trp 6-luteinizing hormone-releasing hormone in anovulatory women. (1978) (9)
Antagonism of ethanol induced sleep-time by alpha-msh, MSH/ACTH4-10 and naloxone. (1980) (9)
Inhibition of the release of growth hormone in vitro by -melanocyte stimulating hormone. (1973) (9)
Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists. (2002) (8)
Inhibition of Sham Feeding-Induced Gastric Secretion and Serum Hormonal Responses by Analogs of (pyro)Glu-His-Gly-OH (1982) (8)
Effects of β-/Tyr9/melanotropin-/9–18/ decapeptide on catecholamine disappearance and serotonin accumulation in discrete brain regions of rats (1981) (8)
Effect of bombesin antagonist D-Phe6-BN(6-13)OMe on vagally induced gastrin release from perfused rat stomach. (1993) (8)
Effect of [(CH2NH)4,5]secretin on pancreatic exocrine secretion in guinea pigs and rats. (1993) (8)
Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. (1989) (8)
DSIP-like immunoreactivity in the developing rat brain (1981) (8)
Synthesis of luteinizing hormone-releasing hormone containing tritium-labelled pyroglutamic acid. (1973) (8)
Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity (1984) (8)
Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens. (1978) (8)
Polyfluoroalkyl derivatives of nitrogen. Part XL. Reaction of trifluoronitrosomethane with NN-bistrifluoromethylamino-substituted allenes (1973) (8)
Blockade of bombesin receptors with [Leu14-ψ(CH2NH)-Leu13]bombesin fails to suppress nutrient-induced CCK release from rat duodenojejunum (1990) (8)
Characteristics of [D-Trp8]-somatostatin-sensitive B50 phosphorylation (1985) (8)
Progress in the development of competitive bombesin antagonists (1987) (8)
Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone (LHRH). (1977) (8)
Kyotorphins affect aversive pecking in chicks (1981) (8)
Some of the α-NH2-acetylated β-endoprhin-like material in rat and monkey pituitary and brain is acetylated α- and β-endorphin (1983) (7)
Effect of enkephalin and naloxone on vagal and hormonal stimulation of pancreatic secretion in man. (1983) (7)
Brain beta-endorphin-like immunoreactivity in adult rats given beta-endorphin neonatally. (1981) (7)
Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat (1991) (7)
DNA and the Digital Data Storage (2019) (7)
Inhibitory activity of four analogs of luteinizing hormone-releasing hormone in vivo. (1975) (7)
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice (2017) (7)
Glp-1 analogue (1999) (7)
Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly (1980) (7)
Anti-Convulsant Drug Valproic Acid in Cancers and in Combination Anti- Cancer Therapeutics (2014) (7)
Blockade of the Pre-ovulatory LH Surge in Hamsters by an Inhibitory Analog of LH-RH 1 (1975) (7)
Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway. (1994) (7)
The interaction between β-[Tyr9]melanotropin-(9–18), haloperidol and amphetamine in different behavior tests of rats (1982) (7)
Effects of endorphins and their analogues on prolactin and growth hormone secretion (1979) (6)
Pituitary Response to Luteinizing Hormone- Releasing Hormone Analog at Sea Level and High Altitudes (1982) (6)
Receptor-selective somatostatin (SRIF) analogs (1988) (6)
Lack of growth hormone-releasing activity of (pyro)Glu-Ser-Gly-NH2. (1973) (6)
Effects of analogs of (pyro)Glu-His-Gly-OH on food consumption and gastric acid secretion in rats. (1984) (6)
Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. (1983) (6)
Poly(bistrifluoromethylamino)-compounds. Synthesis of NN-bistrifluoromethylamino-substituted allenes and their reaction with trifluoronitrosomethane (1970) (6)
A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit (2002) (6)
Development of somatostatin agonists with high affinity and specificity for the human and rat type 5 receptor subtype (2002) (6)
Administration of agonistic and antagonistic analogues of LH-RH induce anovulation in Macaca fasicularis. (1983) (6)
Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines (2007) (6)
Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats (1984) (6)
Role of endogenous bombesin-peptides during vagal stimulation of gastric acid secretion in the rat (1996) (6)
Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues. (1978) (6)
The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues. (2001) (6)
Distribution of 3H-alpha-MSH in rat brain. (1976) (6)
Use of the cutaneous anaphylactoid test to detect differences in mast cell mediator-releasing activity among LHRH peptides. (1987) (5)
Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on passive and active avoidance behavior and on open-field activity of rats (1982) (5)
Gonadotropin release during repeated administration of d-Leu6 des Gly10-LH-RH-EA at different stages of the menstrual cycle and in functional amenorrhea. (1980) (5)
Thyroxine analogues: synthesis of 3,3',5,5'-tetramethyl-L-thyronine. (1972) (5)
The use of a potent stimulatory LHRH analog (D-Trp-6, LHRH) in the induction of ovulation. (1980) (5)
Effects of β-/Tyr9/melanotropin-/9–18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine (1982) (5)
Somatostatin agonists and antagonists--peptide control of growth hormone secretion. (1985) (5)
Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women. (1978) (5)
Central Nervous System Effects after Systemic Injection of Opiate Peptides (1982) (5)
Conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas: effects of N-substituents and reaction conditions on the reaction pathway (2002) (5)
Temporal changes in FSH and LH concentrations following the administration of a potent LH-RH inhibitory analogue ( [N-Ac-D-Trp1, 3, D-p-Cl-Phe2, D-Phe6, D-Ala10]-LH-RH) to oophorectomized rhesus monkeys. (1983) (5)
Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus. (1975) (5)
Proceedings: Investigation and treatment of a recurrent vipoma. (1975) (4)
Comparison of the inhibition of histamine-and pentagastrin-stimulated gastric acid secretion by somatostatin in the cat (1977) (4)
The effects of β-(TYR9)melanotropin-(9–18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine (1983) (4)
Specific labelling of high-affinity vasoactive intestinal peptide receptors in rat liver membranes by a growth hormone-releasing factor analog. (1986) (4)
Effect of reductive alkylation of lysine in positions 6 and/or 8 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. (1987) (4)
Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, beta-endorphin, and (D-Ala2)-beta-endorphin: effects on eating, drinking and activity measures in rats. (1979) (4)
Effect of intracerebroventricular administration of β-/Tyr9/-melanotropin-/9–18/ on rotational behavior induced by substantia nigra lesion in rats (1983) (4)
Polyfluoroalkyl derivatives of nitrogen. Part XXXIX. Preparation of NN-bistrifluoromethylamino-substituted allenes (1973) (4)
Use of the mouse vas deferens assay to evaluate the action of somatostatin peptides on gastric acid secretion. (1981) (4)
Tyrosine 220 in the 5 th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD 168368 * (2000) (4)
The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members. (2012) (4)
Luteinizing hormone (LH), follicle-stimulating hormone, and testosterone responses to consecutive injections of D-leucine-6-LH-releasing hormone ethylamide in normal men. (1977) (4)
Physiological, veterinary and clinical effects of hypothalamic releasing hormones (RH), especially LH-RH (1974) (4)
Selective conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas (2002) (4)
Attempts to induce ovulation in amenorrheic patients using D-Ala-6-LH-RH propylamide. (1979) (4)
Effect of D-Trp6-LH-RH on the pituitary-gonadal axis during the luteal phase in the baboon. (1979) (3)
Structure-activity studies of antagonists of luteinizing hormone-releasing hormone with emphasis on the amino-terminal region. (1987) (3)
Solid-phase synthesis of human pancreatic polypeptide. (2009) (3)
Synthesis of camptothecin–amino acid carbamate linkers (2012) (3)
Effects of Administration of a LH-RH Inhibitory Analogue on Stages of the Rat Estrous Cycle 1 2 (1978) (3)
Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men. (1984) (3)
Structure-activity relationships for relaxation of smooth muscle by VIP (1994) (3)
Bombesin stimulates invasion and migration of lsreco1 colorecial cancer cells in a Rho-dependent manner (2001) (3)
Structural Analysis of Ligand Binding Characteristics for the Bombesin/Gastrin-Releasing Peptide Receptor (1993) (3)
Long-acting luteinizing homone-releasing hormone (LH-RH) analogs in the treatment of female infertility. (1976) (3)
Effects of CRF-like heptapeptide on catecholamine disappearance and serotonin accumulation in different brain areas of rats (1982) (3)
Comparative structural requirements of GRF analogs for occupancy of GRF and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1985) (3)
Polyfluoroalkyl compounds of silicon. Part X. Further silanes containing the bis(trifluoromethyl)amino-group (1974) (3)
Effects of in vivo treatment with an LHRH antagonist analog (D-PHE2-D-PHE6) in the immature male rat. (1978) (3)
The Opioid Neuropeptides Enkephalin and Endorphin and their Hypothesized Relation to Pain (1980) (3)
The Pathogenesis and Therapeutics of Nasopharyngeal Carcinoma (2019) (3)
STRUCTURE ACTIVITY STUDIES ON THE N-TERMINAL REGION OF GLUCAGON (1984) (3)
Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity (1984) (3)
Application of human pancreatic carcinoid BON cells for receptor-targeted drug development (2011) (3)
HETEROGENEITY OF HUMAN GROWTH HORMONE IN PLASMA AND URINE: INFLUENCE OF GROWTH HORMONE RELEASE INHIBITING HORMONE (1975) (3)
Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases. (2015) (3)
Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies. (1980) (2)
Disapearance and excretion of labeled alpha-MSH in man. (1978) (2)
Branched-chain analogs of luteinizing hormone-releasing hormone (1978) (2)
Potent, short, cyclic peptide antagonists of somatostatin (SS) (1983) (2)
Distinct receptors mediate gastrin-releasing peptide and neuromedin beta-induced delay of gastric of liquids in rats. (1995) (2)
Dose response inhibition of the circhoral pulsatile secretion of LH and FSH in rhesus monkeys by the administration of a potent inhibitory analogue of LH-RH ( [N-Ac-D-Trp1, 3, D-p-Cl-Phe2, D-Phe6, D-Ala10]-LH-RH). (1983) (2)
Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain. (1983) (2)
Unaltered plasma GH levels in acromegalics and normal men and women after administration of (Pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing hormone. (1974) (2)
Selective Conversion of O-Succinimidyl Carbamates to N-(O-Carbamoyl)-succinmonoamides and Ureas. (2002) (2)
Conformational scan of bombesin/GRP reveals new position 11 receptor antagonists (1994) (2)
[35] Solid phase synthesis of luteinizing hormone-releasing hormone and its analogues (1975) (2)
Comparison of methionine-enkephalin and morphine in the stimulation of gastric secretion (1978) (2)
(N-Ac-Tyr1.d-Phe2)-θRF(1–29)-NH2 and (d-PHE2)-VIP act as vip antagonists and reduce neurally mediated lower esophageal sphincter (LES) relaxation in the CAT (1986) (2)
Molecular basis of the selectivity of the gastrin-releasing peptide receptor (GRPR) for the neurotransmitter, GRP (2001) (2)
Strategies in the design of synthetic agonists and antagonists of the VIP-glucagon-GRF series (1985) (2)
Polyfluoroalkyl derivatives of nitrogen. Part XXXVII. Reaction of N-bromobistrifluoromethylamine with propene under ionic and free-radical conditions (1972) (2)
Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats. (2008) (2)
Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine. (2009) (2)
Cholera toxin pretreatment of the human lymphoblastic cell line sup T1 affects the selectivity of helodermin/VIP receptors (1989) (2)
Pituitary and Testicular Response to LH‐RH and to a Long‐Acting Analogue (D‐Leu‐6‐LH‐RH‐Ethylamide) (2009) (2)
Pharmacology of GRF and Somatostatin: Positive and Negative Control of GH Release (1994) (2)
Polyfluoroalkyl derivatives of nitrogen. Part XXXVIII. Reaction of N-bromobistrifluoromethylamine with allyl chloride; preparation of NN-bistrifluoromethylprop-2-enylamine (1973) (1)
Conversion of O-Succinimidyl Carbamates to N-(O-Carbamoyl)-succinmonoamides and Ureas: Effects of N-Substituents and Reaction Conditions on the Reaction Pathway. (2002) (1)
Method of modulating cell proliferation of medullary thyroid carcinoma. (2002) (1)
STIMULATION OF GROWTH HORMONE AND PROLACTIN RELEASE BY MORPHINE AND OPIATE-LIKE PEPTIDES (1978) (1)
Effects of a superactive analogue of LH-RH on the hypothalamo-pituitary-testicular axis in male rats pretreated with estrogens. (1981) (1)
Receptors for mammalian bombesin/GRP and neuromedin B have greatly differing ligand binding requirements (1992) (1)
Pharmacology and intracellular signaling of the human bombesin receptor subtype 3 (1998) (1)
Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly. (1984) (1)
Inhibition of testosterone production and pituitary LH-RH binding in rats by LH-RH antagonists (1980) (1)
GRF (1-29) analogs with high in vivo and in vitro potencies in the rat (1992) (1)
Synthesis of D Phe2, Phe3, D Phe6 LH RH, a potent inhibitor of LH RH (1975) (1)
Hypothalamic peptide hormones and their analogues (1978) (1)
CYCLIC ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE WITH SIGNIFICANT BIOLOGICAL ACTIVITIES (1979) (1)
The actions of growth hormone release inhibiting hormone in man (1975) (1)
Endogenous opiates: 1979(1). (1980) (1)
Behavioral effects of D-Ala2-beta-endorphin in squirrel monkeys. (1978) (1)
Clinical Studies With d-Trp6-Luteinizing Hormone-Releasing Hormone in Anovulatory Women**Supported by a grant from Patronato de Investigaciones Endocrino Metabólicas, Fundación General Mediterránea, Madrid, Spain. (1978) (1)
Editorial: GPCR-Targeted Drug Development. (2016) (1)
Novel Tandem Aldol Intramolecular Cyclization of Substituted N-Benzylpiperidine-4-one: Synthesis of Novel-Type Nitrogen 2,8-Phenanthroline Heterocycles (2015) (1)
[Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells. (1988) (1)
Bombesin stimulates bicarbonate and fluid secretion in isolated guinea-pig pancreatic ducts via GRP-preferring bombesin receptors (1998) (1)
Chemical structure and biological activity of hormones and related compounds (1981) (1)
Identification of a simplified polyalaninated VIP analogue with high affinity for human VIP1 receptors (2000) (1)
Pharmacology of Growth Hormone-Releasing Hormone and Its Peptide Analogs (2000) (1)
Structure — Function of LH-RH Analogs and Design Applications to other Peptide Systems (1984) (1)
Gastrin releasing peptide-preferring bombesin binding sites in human lung. (1994) (1)
The utility of reductive alkylation in solid phase peptide synthesis (1988) (1)
Corrigendum to “A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon” [Regul. Pept. 114 (2003) 51–60] (2003) (1)
Potent long-acting alkylated analogs of growth hormone-releasing factor. (1988) (1)
10 lH RH antagonists in females (1984) (1)
Human Serum Albumin (HSA) and ItsApplications as a Drug Delivery Vehicle (2020) (1)
Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist (2002) (1)
Activation of central somatostatin receptor (SSTR) 5 stimulates gastric emptying in rats (1998) (1)
Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on the in vitro uptake and release of radiolabelled dopamine, noradrenaline and serotonin in rat brain hypothalamic slices (1984) (1)
[Response to acute administration of pituitary inhibiting hormone, growth hormone and one of its analogues in acromegaly]. (1975) (1)
EFFECT OF SIMPLE AMINO ACID REPLACEMENTS ON THE BIOLOGICAL ACTIVITY OF LUTEINIZING HORMONE-RELEASING HORMONE (1974) (1)
56 Cranial irradiation for cerebral tumors in childhood–evidence for a hypothalamic defect in growth hormone release (1985) (0)
Intravitreal Injection of Novel Combretastatin Analog MV-5-40 (2003) (0)
Tyr-MIF 1 (Tyr-Pro-Leu-Gly-NH2) Affects Passive Avoidance Behavior but not Motor Activity in Rats, (1983) (0)
Analogs of glucagon-like peptide-1 (GLP-1) (1999) (0)
POLYFLUORALKYL DERIVATIVES OF NITROGEN PART 38, REACTION OF N-BROMOBISTRIFLUOROMETHYLAMINE WITH ALLYLCHLORIDE, PREPARATION OF N,N-BISTRIFLUOROMETHYLPROP-2-ENYLAMINE (1973) (0)
Native human bombesin receptor subtype 3 has a unique pharmacology (1998) (0)
INITIAL BIODISTRIBUTION STUDIES OF A RADIOIODINATED GASTRIN RELEASING PEPTIDE (GRP) ANTAGONIST: A POTENTIAL ONCOLOGICAL DETECTION AGENT (1998) (0)
Anti-luteinizing (LH)-releasing activity of several analogues of LH-releasing hormone. (1975) (0)
Distribution of radioimmunoassayable PACAP: Abundance in the brain and testes (1992) (0)
A synthetic bombesin-analogue acting as specific bombesin receptor antagonist (1988) (0)
A method for preparing an octapeptide (1986) (0)
Somatostatin-induced augmentation of the descending phase of the peristaltic reflex is mediated by the somatostatin receptor type 2 (SST2) (2000) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF POSITION 1 ANALOGS OF LH-RH (1977) (0)
Vasoactive intestinal peptide (VIP) structural requirements for high affinity interaction with the VIP receptor in pancreatic acini (1998) (0)
Solid phase synthesis on luteinizing hormone-releasing hormone and its analogues. (1975) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF LH-RH ANALOGS MODIFIED AT THE CARBOXYL TERMINUS (1975) (0)
Synthesis and biological actions of prosomatostatin ( somatostatin / synthetic prohormone / insulin / glucagon / growth hormone ) (0)
Somatostatin (SST) enhances cAMP-dependant shortcircuit current (Isc) in human colon via SST receptor subtype-2 (SSTR-2) (1998) (0)
Mo1784 Identification of Selective Agonists for the Hpac1 Receptor (2014) (0)
Abstracts of the Hans Selye Symposium on Neuroendocrinology and Stress (1989) (0)
Method for the synthesis of a peptide containing a non-peptide bond. (1987) (0)
Physiological studies on the LH- and FSH- releasing hormone its analogues, and antisera. (1974) (0)
Therapeutically active peptides, particularly bombesinantagonistiske litorinantagonistiske and peptides as well as process for their preparation (1989) (0)
Responses of serum GH and somatomedin-C to an analogue of GHRH in children with growth hormone deficiency (1984) (0)
IMPROVED ANTAGONISTS OF LUTEINIZING HORMONE-RELEASING HORMONE MODIFIED IN POSITION 7 (1985) (0)
133 Bombesin Receptor Subtype-3 Signaling Targets Glut4 Translocation in Human Adipocytes (2009) (0)
Behavioural Modulation by Systemic Administration of Enkephalins and Endorphins (1981) (0)
[Synthetic hypothalamic gonadotropin-releasing hormone (LH-RH) and ovulation: a possibility of "programmed" ovulation to regulate fertility in women (author's transl)]. (1975) (0)
The orphan receptor, BRS-3, causes tyrosine phosphorylation (TYR-P) of focal adhesion kinase (p125FAK) (1998) (0)
Role for somatostatin receptors in discriminating between mechanosensitive release of 5-HT and PGE2 in the initiation of secretory reflexes in the guinea pig colon* (1998) (0)
Letter: Analogues of growth-hormone release-inhibiting hormone. (1975) (0)
[Synthetic hypothalamic gonadotropin-releasing hormone -- LH-RH -- and ovulation: a possibility of programmed ovulation to control fertility in women.)] (1975) (0)
Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin. (1984) (0)
Reduced Peptide Bond Pseudopeptide Analogues of Secretin (2001) (0)
Identification and exploitation of structural foci that influence conformational mobility in somatostatin agonists and antagonists (2002) (0)
Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus (endorphins/pro-hormones) (0)
POLYFLUOROALKYL DERIVATIVES OF NITROGEN PART 40, REACTION OF TRIFLUORONITROSOMETHANE WITH NN-BISTRIFLUOROMETHYLAMINO-SUBSTITUTED ALLENES (1973) (0)
Foerfarande Foer framstaellning of nya tillvaexthormon frigoerande-like peptides. (1984) (0)
Synthesis of camptothecin–amino acid carbamate linkers (2011) (0)
Stimulation of Prolactin and Growth Hormone Release by Intraventricular Injection of Met-Enkephalin, β-Endorphin and Endorphin Analogues in the Rat (1978) (0)
Isolation , structure , biological characterization , and synthesis of f 3-[ Tyr 9 ] melanotropin-( 9-18 ) decapeptide from pig hypothalami ( aand P-melanottopin / {-lipotropin / corticotropin precursor ) (0)
FACILE SOLID-PHASE PREPARATION OF PEPTIDES CONTAINING THE CH2NH PEPTIDE BOND ISOSTERE AND APPLICATION TO THE SYNTHESIS OF SOMATOSTATIN (SRIF) OCTAPEPTIDE ANALOGUES (1987) (0)
Cyclic Bombesin/GRP Analogs Which Retain Either Agonist or Antagonist Activity, (1992) (0)
New potent somatostatin receptor 2 antagonist inhibits srif and srif-mediated effects on pentagastrin-stimulated gastric acid secretion in conscious rats (1998) (0)
114 Immune responsiveness in rats following hypophysectomy (1988) (0)
W1581 The Pharmacophore for Human Bombesin Receptors(BnR) Differs Significantly from That of Rat (2009) (0)
Alternative bridging groups for proline in endothelin pentapeptide receptor antagonists (1994) (0)
Development of a novel high affinity bombesin (BN)-camptothecin analog and demonstration of its ability to effect receptor-related cytotoxicity in normal and tumor cells (2003) (0)
PROC.V INT.CONGR.ENDOCRINOLOGY. VOL.I (1977) (0)
Present status of LH-RH analog chemistry (1985) (0)
The non-therapeutic method of promoting the release of growth hormone in an animal (2005) (0)
S1821 The Attenuating Action of Vasoactive Intestinal Peptide (VIP) on Pancreatic Inflammation is Mediated by Ameliorating Both Oxidative Stress Effects and Cytokine Production (2010) (0)
Isolation and characterization of novel hypothalamic polypeptides homologous with VIP (1989) (0)
Therapeutic efficacy of LHRH analoger. (1985) (0)
D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties. (1992) (0)
DB110690 197..207 (2011) (0)
PHYSIOLOGICAL, VETERINARY, AND CLINICAL EFFECTS OF HYPOTHALAMIC RELEASING HORMONES (RH), ESPECIALLY LH‐RH (1974) (0)
Oktapeptidanaloge of somatostatin with threonine at position 6 (1990) (0)
Effect of cycloheximide on the LH release induced by a superactive analog of LH-RH. (1980) (0)
Blockade of GRP receptors inhibits gastric acid secretion independent of plasma gastrin release in humans (2000) (0)
Somatostatin analogs selective for sub-type 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenomas cultured in vitro (1998) (0)
W1758 Selectivity and Potency of Putative Neuromedin B Receptor (Nmbr) Antagonists for Human Bombesin Receptors (Bnr) (2008) (0)
S1707 Assessment of a New, Novel, Putative High Affinity and Selective Ligand for the Hbrs3 Receptor and Comparison to Older Less Selective Ligands (2010) (0)
Rational design of peptide agonists selective for the bombesin receptor subtype 3 (2000) (0)
Therapeutically effective peptides (1991) (0)
POLYFLUOROALKYL DERIVATIVES OF NITROGEN PART 39, PREPARATION OF N,N-BISTRIFLUOROMETHYLAMINO-SUBSTITUTED ALLENES (1973) (0)
Peptides as drug (1989) (0)
Effects of secretin, VIP, CRF, and other neuro-gastrointestinal peptides on rat insulin and glucagon levels (1983) (0)
Comparative efficacy of synthetic glucagon analogs on rat liver and heart adenylate cyclase (1985) (0)
VPAC1 receptors as molecular targets in breast cancer (2006) (0)
STRUCTURE-ACTIVITY STUDIES ON THE N-TERMINAL REGION OF GROWTH HORMONE RELEASING FACTOR (1985) (0)
Treatment of cancer with somatostatin analogue with it. (1988) (0)
SYNTHESIS AND BIOLOGICAL PROPERTIES OF THE 2-L-β-(PYRAZOLYL-1)ALANINE ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE AND THYROTROPIN-RELEASING HORMONE (1976) (0)
LHRH antagonists and contraception. (1985) (0)
Correlation between leuteinizing hormone responses to luteinizing hormone-releasing hormone (LH-RH) and to D-leu-6-LH-RH-ethylamide in patients with hypothalamo-pituitary disease. (1976) (0)
Contents, Vol. 45, 1987 (1987) (0)
First neuromedin B receptor antagonists are based on somatostatin octapeptide analogues (1994) (0)
STRUCTURE-DEPENDENT INHIBITORY EFFECT OF GALANIN ON INSULIN, GASTRIC ACID AND PANCREATIC AMYLASE SECRETION IN RAT (1993) (0)
A process for the preparation of peptides having growth hormone releasing activity (1994) (0)
Discovery of a selective agonist for the novel bombesin (BN) receptor subtype 3 (2000) (0)
Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (0)
Endogenous Opiate Systems May Modulate Learning and Memory (1984) (0)
Study of Antiangiogenic Somatostatin Conjugate (JF–10–81) (2004) (0)
Toxicity of a possible therapeutic GRF analogue in vivo in monkeys but in rats is likely due to VIP receptor agonist activity (2000) (0)
Structural determinants of high affinity VIP2-R (VPAC2) interaction and identification of a simplified high affinity agonist (2001) (0)
The effect of beta-(Tyr9)melanotropin-(9-18) on the active avoidance and open-field behavior on rats pretreated with atropine or propranolol. (1984) (0)
Differentiation of somatostatin receptors involved in inhibition of gastric acid and growth hormone secretion with halogenated Trp8 analogues [proceedings]. (1978) (0)
Use of octapeptides for the treatment of receptor associated diseases neuromedin b. (1993) (0)
Levels of Luteinizing Hormone (LH), Follicle-Stimulating Hormone, and 17β-Estradiol in Response to D-Trp6-LH-Releasing Hormone During Different Phases of the Menstrual Cycle in Normal Women**Supported by a grant from Patronato de Investigaciones Endocrino Metabolicas, Fundacion General Mediterranea, (1978) (0)
United States Patent ( 19 ) Coy et al . 54 BRADYKININ ANALOGS WITH NON-PEPTDE BOND 75 Inventors : (2017) (0)
Galanin inhibits sodium oleate-stimulated CCK release from STC-1 cells* (1998) (0)
ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE CONTAINING DERIVATIVES OF PHENYLALANINE IN PLACE OF TYROSINE (1973) (0)
The effect of analogues of hypothalamic hormones on the growth of the Swarm chondrosarcoma (1982) (0)
[Biological studies with enkephalins and endorphins and their analogs]. (1978) (0)
SYNTHESIS AND BIOLOGICAL PROPERTIES OF (2-L-BETA-(PYRAZOLYL-3)ALANINE)-LUTEINIZING HORMONE-RELEASING HORMONE (1974) (0)
Peptide-Neuromedin B (NMB) Receptor Interactions: Comparison with Gastrin-Releasing Peptide (GRP) Receptor Interactions (1993) (0)
Elucidation of receptor domains of gastrin-releasing peptide receptor (GRPR) determining high selectivity for peptide antagonists (1998) (0)
Agonists and antagonists of urotensin-ii. (2001) (0)
Tissue distribution of PACAP receptor subtypes in rat (1992) (0)
Inhibition by LHRH antagonist of steroid secretion from luteal and leydig cells in vitro (1984) (0)
The method of therapeutically useful, and for the preparation of modified bombesin litoriinipeptidianalogien (1989) (0)
Pituitary Adenylate Cyclase Activating Peptide Receptors Regulate the Growth of Non-Small Cell Lung Cancer Cells 1 (2006) (0)
Effect of the carboxyl terminus of the human VIP2 receptor (VPAC2) on receptor affinity, adenylate cyclase activation and receptor internalization (2001) (0)
Subject Index Vol. 45, 1987 (2004) (0)
Erratum to ‘Gastrin releasing peptide-preferring bombesin binding sites in human lung’ [Eur. J. Pharmacol. 265 (1994) 117–120] (1995) (0)
Plasma gonadotropin response to D-Ala6-LH-RH propylamide. (1978) (0)
Somatostatin Analogs therapeutic. (1987) (0)
POLYFLUOROALKYL COMPOUNDS OF SILICON PART 10, FURTHER SILANES CONTAINING THE BIS(TRIFLUOROMETHYL)AMINO‐GROUP (1974) (0)
Selective Somatostatin Receptor Type 2 Antagonism Prevents Hypoglycaemia In Type 1 Diabetic BB Rats (2012) (0)
Influence of methionine-enkephalin and morphine on the myoelectrical activity of the small bowel (1978) (0)
Evaluation of Intravitreal Toxicity of Somatostatin Conjugate (JF-10-81), an Antiangiogenic Compound (2003) (0)
Somatostatin : A potent , selective inhibitor of growth hormone release ( peptides / pituitary / bioassay / receptors / somatotropin ) (2003) (0)
Comparative structural requirements of GRF analogs for occupancy and coupling to adenylate cyclase of GRF- and VIP receptors (1985) (0)
Thyrotrophin and prolactin response to beta-(pyrazolyl-1)-alanine-2-TRH in normal males. (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David H. Coy?

David H. Coy is affiliated with the following schools:

David H. Coy's Academic­Influence.com Rankings

Why Is David H. Coy Influential?

David H. Coy's Published Works

Published Works

What Schools Are Affiliated With David H. Coy?

David H. Coy's AcademicInfluence.com Rankings